Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
12.76
-0.19 (-1.47%)
May 20, 2026, 1:55 PM CST

SHE:002907 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
788.12815.21764.14680.84774.72837.23
Other Revenue
11.9311.9310.6810.710.478.91
800.05827.14774.82691.54785.18846.14
Revenue Growth (YoY)
1.87%6.75%12.04%-11.93%-7.20%-4.12%
Cost of Revenue
341.4353.96332.91312.45320.55400.53
Gross Profit
458.64473.18441.91379.1464.63445.61
Selling, General & Admin
309.39317.2308.36263.88292.53297.82
Research & Development
96.9489.7659.1378.1258.8241.72
Other Operating Expenses
12.1513.2212.1111.0112.3411.58
Operating Expenses
418.68420.38381.01351.31367.04350.65
Operating Income
39.9752.860.927.7897.5994.95
Interest Expense
-0.14-0.14--0.95-14.42-18.22
Interest & Investment Income
15.8814.7910.329.8111.516.4
Currency Exchange Gain (Loss)
0.020.020-0--
Other Non Operating Income (Expenses)
-1.24-0.30.27-0.17-0.03-0.03
EBT Excluding Unusual Items
54.4867.1771.4936.4894.6493.11
Gain (Loss) on Sale of Investments
2.331.421.38-4.67-2.61-1.33
Gain (Loss) on Sale of Assets
10.2510.25-0.06--0.01
Asset Writedown
-0.36-0.44-0.03-2.37-0.17-
Other Unusual Items
-0.94-0.9420.613.316.3711.65
Pretax Income
65.7677.4693.4442.8108.24103.42
Income Tax Expense
21.9922.2516.7110.19.8411.64
Earnings From Continuing Operations
43.7655.2176.7332.798.491.78
Minority Interest in Earnings
13.769.88----
Net Income
57.5265.0976.7332.798.491.78
Net Income to Common
57.5265.0976.7332.798.491.78
Net Income Growth
-25.04%-15.17%134.66%-66.77%7.21%-22.99%
Shares Outstanding (Basic)
417417418418403401
Shares Outstanding (Diluted)
417417418418403401
Shares Change (YoY)
-0.05%-0.05%0.02%3.60%0.49%0.06%
EPS (Basic)
0.140.160.180.080.240.23
EPS (Diluted)
0.140.160.180.080.240.23
EPS Growth
-25.00%-15.13%134.61%-67.92%6.69%-23.04%
Free Cash Flow
45.747.68145.62126.52-47.5726.21
Free Cash Flow Per Share
0.110.110.350.30-0.120.07
Dividend Per Share
0.0750.0750.0850.0500.0700.050
Dividend Growth
-11.77%-11.77%70.00%-28.57%40.00%78.57%
Gross Margin
57.33%57.21%57.03%54.82%59.17%52.66%
Operating Margin
5.00%6.38%7.86%4.02%12.43%11.22%
Profit Margin
7.19%7.87%9.90%4.73%12.53%10.85%
Free Cash Flow Margin
5.71%5.76%18.79%18.30%-6.06%3.10%
EBITDA
125.38138.5147.74109.68172.13164.7
EBITDA Margin
15.67%16.74%19.07%15.86%21.92%19.46%
D&A For EBITDA
85.4185.786.8481.974.5469.74
EBIT
39.9752.860.927.7897.5994.95
EBIT Margin
5.00%6.38%7.86%4.02%12.43%11.22%
Effective Tax Rate
33.45%28.72%17.89%23.59%9.09%11.25%
Revenue as Reported
827.14827.14774.82691.54785.18846.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.